Blog
Defendants Can’t Recover IPR Fees or Hold Opposing Counsel Liable in Patent Disputes
May 20, 2024
Dragon Intell. Prop. LLC v. DISH Network L.L.C Authored by: Jeremy J. Gustrowsky A recent appellate decision clarifies the limits of attorney fee awards in patent disputes, especially when a defendant prevails by invalidating a patent through inter partes review…
Read MorePREP Act Immunity Claim Stalls Patent Dispute Over COVID-19 Swabs
May 14, 2024
Copan Italia SpA v. Puritan Med. Prods. Co. LLC Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit highlights the limits of immediate appeals when it comes to claims of immunity under the Public Readiness and Emergency…
Read MorePatent Owners Must Show Investments Tied to Each Patent to Succeed at the ITC
May 8, 2024
Zircon Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky A recent decision highlights the importance of how patent owners present evidence when seeking relief at the International Trade Commission (ITC). In a dispute over electronic stud finders, Zircon…
Read MoreAmazon Patent Takedown Triggers Jurisdiction Over Out-of-State Patent Owner
May 2, 2024
SnapRays v. Lighting Def. Grp Authored by: Jeremy J. Gustrowsky A recent decision highlights how using Amazon’s patent enforcement tools can land a patent owner in court far from home. In this case, Lighting Defense Group (LDG), an Arizona company,…
Read MorePatent Infringement Awards Can Disappear If Patents Are Later Found Invalid
May 2, 2024
Packet Intel. LLC v. NetScout Sys Authored by: Jeremy J. Gustrowsky A recent decision highlights a critical risk for patent owners: even after winning a patent infringement lawsuit and being awarded damages, those awards can vanish if the underlying patents…
Read MorePrinted Matter Doctrine Narrowed: Federal Circuit Clarifies Limits in Patent Disputes
May 1, 2024
IOENGINE, LLC v. Ingenico Inc Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit has clarified how the “printed matter doctrine” applies to modern technology patents, particularly those involving software and encrypted communications. The case centered on…
Read MorePatent Owners Keep Standing Even When Lenders Hold Some Rights
May 1, 2024
Intell. Tech. LLC v. Zebra Techs. Corp Authored by: Jeremy J. Gustrowsky A recent decision clarifies an important issue for patent owners who have granted security interests in their patents to lenders. The case involved Intellectual Tech LLC, which owned…
Read MoreTrademark Board’s Extension and Evidence Decisions Upheld in Hair Product Mark Dispute
April 30, 2024
Araujo v. Framboise Holdings Inc Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit highlights how the Trademark Trial and Appeal Board (TTAB) handles requests for more time and the kind of evidence needed to prove who…
Read MoreUSPTO Invention-Con on the Road
April 29, 2024
Invention-Con is the USPTO’s annual conference for independent inventors, entrepreneurs, and small-business owners whose success depends on guarding their creative work. Tailored for the independent inventor community, this free marquee event brings inspiration and resources directly to you. Connect with fellow…
Read MoreCelebrating innovative, creative and enterprising changemakers around the world
April 26, 2024
Every April 26, we celebrate World Intellectual Property Day to learn about the role that IP rights play in encouraging innovation and creativity. In 2024 World IP Day celebrates changemakers worldwide who are driving the innovation and creativity needed to…
Read MoreToddler Dining Mat Patent Dispute Highlights Importance of Candor in Patent Litigation
April 12, 2024
Luv N’ Care, Ltd. v. Laurain Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit sheds light on the high stakes of honesty and fair play in patent lawsuits, especially when it comes to innovative products for…
Read MoreCourt Affirms Obviousness of Rifaximin Patents, Clarifies ANDA Approval Timing
April 11, 2024
Salix Pharms., Ltd. v. Norwich Pharms. Inc Authored by: Jeremy J. Gustrowsky A recent appellate decision sheds light on the complex interplay between pharmaceutical patents, generic drug approvals, and the standards for proving a patent is “obvious” in light of…
Read More